ResMed makes $305m US asthma tech buy
SYDNEY: ResMed chief executive Mick Farrell says the acquisition of an innovative start-up that helps
SYDNEY: ResMed chief executive Mick Farrell says the acquisition of an innovative start-up that helps
FEATURED
More are reaching retirement with mortgage as first home buyers get older
Tens of thousands to be recruited into Alzheimer’s trials after landmark drug rejected
Best retirement housing design for Global Awards shortlisted
Retirement apartments to be woven into mixed-use development
Thousands of dementia sufferers are being denied new miracle drug
Property group reveals revised mixed-use housing development plans
INNOVATION
